Pulmonx (LUNG) Share-based Compensation (2019 - 2025)

Pulmonx (LUNG) has reported Share-based Compensation for 7 consecutive years, with $5.2 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Share-based Compensation rose 638.0% year-over-year to $5.2 million in Q3 2025; TTM through Sep 2025 was $22.5 million, a 77.69% increase from a year earlier, with the FY2024 full-year figure at $23.0 million, up 3.86% from the prior year.
• Share-based Compensation was $5.2 million for Q3 2025 at Pulmonx, down from $6.2 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $6.2 million in Q2 2025 and troughed at $700000.0 in Q2 2024.
• A 5-year average of $4.1 million and a median of $4.4 million in 2022 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation jumped 5583.02% in 2021 and plunged 88.34% in 2024, its largest moves.
• Over 5 years, Share-based Compensation stood at $3.0 million in 2021, then jumped by 41.0% to $4.2 million in 2022, then soared by 31.81% to $5.6 million in 2023, then retreated by 1.34% to $5.5 million in 2024, then retreated by 6.46% to $5.2 million in 2025.
• The last three Share-based Compensation figures came in at $5.2 million (Q3 2025), $6.2 million (Q2 2025), and $5.6 million (Q1 2025), per Business Quant data.